Science and Technology Daily (Reporter Dong Yingbi) A research team composed of 3 scientific research institutions including Tomsk University of Technology in Russia has developed a new method for imaging cancer tumor metastases.
Modern medicine has found that it is easier to treat cancer in the early stages, and the primary tumor can be removed or radiotherapy can be applied to it
From the Tomsk Polytechnic University, the Russian Academy of Sciences Shemya gold and Ovchinnikov Institute of Organic Chemistry and Biological Russian Academy of Sciences, Tomsk National Research Medical Center research team composed of the development of drug forms for personalized treatment of substance , Especially found the radionuclide for target imaging for the treatment of tumor diseases
Academy of Sciences However, compared with the pharmaceutical substances developed by Tomsk University of Technology, EpCAM drugs usually contain severe toxins or cytotoxic compounds, which may cause serious adverse reactions in patients
Academician of the Academy of Sciences According to Vladimir Tolmachev, director of the Oncology Research Center of Tomsk University of Technology, the proteins are labeled with radionuclides, which can identify therapeutic targets
Vladimir Tolmachev said that the targets that researchers are studying exist in pancreatic cancer, ovarian cancer, prostate cancer and other diseases.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
